Investigation of risk factors for tonsillopharyngitis with macrolide resistant Streptococcus pyogenes in Turkish

Ergin Ciftçi1, Ulker Dogru, Haluk Güriz

  • 1Department of Pediatrics, Ankara University Medical School, Ankara, Turkey. erginciftci@doctor.com

Insights

Family macrolide antibiotic use is a significant risk factor for developing tonsillopharyngitis caused by macrolide-resistant Streptococcus pyogenes. Restricting macrolide use can help prevent resistant infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Streptococcus pyogenes is a primary cause of tonsillopharyngitis.
  • Penicillin is the preferred treatment, but macrolides are alternatives for allergic patients.
  • Increasing macrolide resistance in S. pyogenes necessitates investigation into risk factors.

Purpose of the Study:

  • To identify risk factors associated with tonsillopharyngitis caused by macrolide-resistant S. pyogenes.
  • To understand the development of antibiotic resistance in pediatric tonsillopharyngitis.

Main Methods:

  • Investigated 345 children diagnosed with S. pyogenes tonsillopharyngitis.
  • Assessed various potential risk factors for infection.
  • Determined antibiotic susceptibility of isolated S. pyogenes strains to erythromycin, clarithromycin, and azithromycin.

Main Results:

  • Macrolide resistance rates were 3.8% for erythromycin and 4.2% for clarithromycin and azithromycin.
  • Recent macrolide antibiotic use within the family (3 months) was a significant risk factor (OR=7.04, P=0.005).
  • Identified family macrolide exposure as a key predictor of resistant S. pyogenes infections.

Conclusions:

  • Limiting macrolide antibiotic consumption is crucial for preventing tonsillopharyngitis due to macrolide-resistant S. pyogenes.
  • This finding supports antimicrobial stewardship programs to combat antibiotic resistance.
  • Further research into resistance mechanisms and broader public health interventions is warranted.
Abstract

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...